Kewaunee Scientific ($KEQU): A Full Year of Nu Aire Masks a 23% Backlog Collapse Heading Into FY2027

⚠ Major Risks

• •Order backlog fell to $165.9M at April 30, 2026 from $214.6M a year earlier (a ~$48.7M, ~23% drop), pointing to a softening forward revenue pipeline even though management expects ≥90% of it to ship in FY2027.
• •Heavy customer concentration: two domestic dealers plus the national stocking distributor were ~34% of FY2026 sales (41% in FY2025); loss of any one would materially hit revenue and profit.
• •Nu Aire integration and impairment exposure: the November 2024 acquisition was debt-funded (seller notes, Term Loan B, revolving facility, amended loan agreements) and carries goodwill and acquired intangibles the company explicitly flags as impairment-prone.
• •Firm-price quotes on long-lead construction orders leave the company bearing raw-material and tariff inflation (steel, stainless, wood, epoxy resin) between quote and delivery, with no guarantee it can raise prices to match.
• •Cyclical end-market and funding risk: revenue depends on lab/healthcare construction activity and government research funding, with 28% of FY2026 revenue from outside the U.S. (FX, geopolitical, and trade-policy exposure).

🔍 Accounting Red Flags

• ▲Revenue-timing judgment: significant over-time recognition tied to construction projects, plus retention amounts collected only at project completion, makes reported sales and working capital sensitive to project timing and management estimates.
• ▲Goodwill and acquired intangibles from Nu Aire create future impairment risk that management warns could be material if demand keeps softening (consistent with the falling backlog).
• ▲2022 sale-leaseback of the Statesville manufacturing/office facilities converted owned real estate into long-term lease obligations — a financing structure that should be examined alongside the debt stack.
• ▲No independent auditor attestation on internal control over financial reporting (the Section 404(b) box is unchecked) — permitted as a smaller reporting / non-accelerated filer, but it means ICFR is management-assessed only.

💰 Cash Flow Quality

The full cash-flow statement is outside the provided excerpt, but the disclosed model — retention-heavy, long-DSO collections layered on a debt-funded acquisition and a declining backlog — points to a working-capital-intensive, leveraged cash profile.

• •Management states payments are typically received in the quarter following shipment, with retention amounts held until final project completion, structurally inflating required working capital.
• •A listed risk is 'failing to generate sufficient future positive operating cash flows and, if necessary, secure and maintain adequate external financing.'
• •Acquisition and operations are supported by a multi-layer debt stack (seller notes, Term Loan B, revolving credit facility, amended loan agreements) plus a 2022 sale-leaseback.
• •A ~23% backlog decline implies softer future shipments and collections unless bookings recover.

🏰 Competitive Position

A 120-year-old niche brand with genuine specification and channel advantages, but one that competes heavily on price through public bidding, which caps pricing power.